Report updated May 20, 2026

TL;DR:UpToDate Lexidrug defends its clinical-reference market position through multidisciplinary editorial authority, yet the app faces a critical retention risk as persistent technical regressions in database downloads and authentication loops drive professional users toward more stable alternatives. Users feel Frustrated, praising reliable clinical reference content remains a daily essential for medical professionals in clinical settings but frustrated by persistent database download failures prevent access to critical drug interactions and compatibility information. UpToDate Lexidrug maintains a strong clinical moat through editorial rigor, but technical instability in the latest release is actively driving professional churn, so the team must prioritize stability over feature expansion to protect the subscription base..|TL;DR:UpToDate Lexidrug defends its clinical-reference market position through multidisciplinary editorial authority, yet the app faces a critical retention risk as persistent technical regressions in database downloads and authentication loops drive professional users toward more stable alternatives. Users feel Frustrated, praising reliable clinical reference content remains a daily essential for medical professionals in clinical settings but frustrated by persistent database download failures prevent access to critical drug interactions and compatibility information. UpToDate Lexidrug maintains a strong clinical moat through editorial rigor, but technical instability in the latest release is actively driving professional churn, so the team must prioritize stability over feature expansion to protect the subscription base..

UpToDate Lexidrug is a challenged medical app that is available. With a 4.2/5 rating from 7.6K reviews, it faces significant user friction. Users particularly appreciate reliable clinical reference content remains a daily essential for medical professionals in clinical settings, though persistent database download failures prevent access to critical drug interactions and compatibility information remains a common concern.

What is UpToDate Lexidrug?

UpToDate Lexidrug is a professional-grade drug reference app providing clinical monographs, interaction checkers, and medical calculators for healthcare providers.

Clinicians hire this tool for evidence-based, offline-accessible drug information that ensures patient safety during point-of-care decisions.

Current Momentum

v9.4 · 1w ago

Maintenance
  • Ships general bug fixes only.
  • Last major release Apr 2026.
AI-powered deep analysis surfacing high-signal insights. Still in beta, accuracy improves daily. For informational purposes only.

Active Nemesis

Drugs.com Medication Guide

Drugs.com Medication Guide

By Drugs.com

Other Rivals

Sanford Guide Antimicrobial
Merck Manual Professional
DynaMed
Calculate by QxMD
Figure 1 - Medical Cases
Micromedex
Pill Identifier by Drugs.com

7-Day Rank Pulse 🇺🇸

Medical

No ranking data

Rating Pulse 🇺🇸

Recent User MoodAI-powered deep analysis surfacing high-signal insights. Still in beta, accuracy improves daily. For informational purposes only.

What makes this app unique?

What Does It Look Like?

How Is The App's Momentum Right Now?

Loading...

What Are The Key Features?

Drug Interaction CheckerStandard

Interactive tool to identify potential adverse reactions between multiple medications

Offline Database AccessDifferentiator

Ability to store drug monographs and clinical content locally on the device

Medical CalculatorsStandard

Integrated suite of hundreds of clinical calculators for dosing and therapeutic support

Multidisciplinary Editorial UpdatesDifferentiator

Clinical information reviewed and updated daily by an internal editorial team

How much does it cost?

Subscription
  • 14-day free trial
  • $29.99/month

Subscription model anchored at $29.99/month, targeting professional users with a 14-day trial conversion funnel.

Who Built It?

Lexi-Comp app icon

Providing healthcare professionals with evidence-based drug information and clinical decision support tools at the point of care.

Portfolio

1

Apps

Who is Lexi-Comp?

Lexi-Comp operates as a specialized medical vertical within the Wolters Kluwer professional information ecosystem, focusing on high-utility clinical reference tools. Their moat is built on deep institutional integration and a reputation for evidence-based accuracy, making them a standard in hospital and pharmacy workflows. The recent integration of the 'UpToDate' branding suggests a strategic consolidation of medical assets to provide a unified clinical decision platform for enterprise healthcare providers.

Who is Lexi-Comp for?

  • Healthcare professionals
  • Pharmacists
  • Physicians
  • Nurses requiring real-time drug interaction
Steady

Portfolio momentum

Maintained a consistent development cycle with 4 releases in the last 6 months, including a major update to their flagship title within the last 3 days.

Last release · 3d agoActive apps · 1

What do users think recently?

High confidence · Latest 66 of 106 total reviews analyzed · Based on 106 reviews. Signal may be noisy.

How did the latest release land?

Overall
4.2/ 5
(7.6K)
Current version
4.7/ 5
+0.5 vs overall
(3.7K)
Main signal post-update: reliable clinical reference content remains a daily essential for medical professionals in clinical settings.

What is the recent mood?

Frustrated

Recent user voice shows a frustrated sentiment. Users appreciate reliable clinical reference content remains a daily essential for medical professionals in clinical settings, but report persistent database download failures prevent access to critical drug interactions and compatibility information and ui navigation changes hide essential drug library tools behind excessive menu clicks post-update.

What Users Love

Reliable clinical reference content remains a daily essential for medical professionals in clinical settings

What Frustrates Users

Persistent database download failures prevent access to critical drug interactions and compatibility information
UI navigation changes hide essential drug library tools behind excessive menu clicks post-update
Authentication and update loops lock users out of paid content despite active subscriptions

What Users Want

Restoration of direct home screen access to the primary drug library database

What is the competitive landscape for UpToDate Lexidrug?

How's The Medical Market?

**Pricing**: Subscription model at $29.99/month, anchored by a 14-day free trial funnel. **Performance**: The app maintains a consistent presence in the Medical category, with #17 Grossing in the US and #33 Grossing across multiple international markets, though free-tier chart rankings fluctuate significantly (e.g., #81 to #189 in various regions).

How does it evolve in the Medical market?

UpToDate Lexidrug holds a #17 Grossing position in the US Medical category, reflecting strong professional monetisation despite a high-friction UI. The gap between its high-value clinical content and the recent technical instability creates a vulnerability to niche competitors.

ChartRankChange
AndroidGrossing#30
AndroidGrossing#31

The rivals identified

The Nemesis

Head to Head

The target app must emphasize its clinical depth and professional-grade decision support to differentiate from the broader, high-volume reach of Drugs.com.

What sets UpToDate Lexidrug apart

  • Delivers specialized clinical-grade monographs and therapeutic decision support tools tailored specifically for healthcare professionals.

  • Maintains a more rigorous editorial standard for multidisciplinary clinical evidence compared to general consumer references.

What's Drugs.com Medication Guide's Edge

  • Leverages a massive user base to drive higher engagement and broader visibility in general app store searches.

  • Provides a more accessible, user-friendly interface that caters to both patients and busy clinicians needing quick answers.

Contenders

Sanford Guide Antimicrobial

Sanford Guide Antimicrobial

4.8 (4.5K)

Antimicrobial Therapy, Inc.

Highly specialized niche leader with strong professional loyalty and consistent update velocity.

Focuses exclusively on antimicrobial therapy, creating a deep, specialized workflow that general apps cannot replicate.

Maintains a high update frequency of 7 releases in six months, reflecting a commitment to current clinical guidelines.

Merck Manual Professional

Merck Manual Professional

4.8 (999)

Merck & Co Inc

🚀

A trusted, authoritative brand that provides high-quality clinical content for medical professionals.

Leverages the prestigious Merck Manual brand to establish immediate clinical authority and trust with medical professionals.

Provides comprehensive, peer-reviewed medical content that serves as a primary reference for complex clinical decision-making.

Peers

DynaMed

DynaMed

4.9 (3.5K)

EBSCO Publishing

📈

A direct competitor in the clinical decision support space, focusing on evidence-based medicine.

Integrates evidence-based clinical summaries designed specifically for rapid point-of-care decision support in hospital settings.

Utilizes a robust editorial process that prioritizes the most current clinical evidence over general drug information.

Calculate by QxMD

Calculate by QxMD

4.5 (13.2K)

WebMD

📈

Adjacent toolset focusing on clinical calculators rather than drug monographs.

Provides a vast library of clinical calculators that streamline complex medical scoring and risk assessment workflows.

Offers a highly interactive user experience that complements static drug reference apps like the target.

Figure 1 - Medical Cases

Figure 1 - Medical Cases

4.1 (13.5K)

Figure 1, Inc.

A social-professional network that provides clinical context through shared medical cases.

Facilitates peer-to-peer learning through a visual, case-based social network for healthcare professionals.

Drives high engagement through community-driven discussions on rare and complex clinical presentations.

Micromedex

Micromedex

3.8 (327)

Merative

🔧

A legacy professional drug reference tool that competes directly for the clinical audience.

Provides deep, institutional-grade drug information that is often integrated into hospital-wide clinical systems.

Focuses on high-stakes clinical safety data, catering to the specific needs of pharmacists and hospital clinicians.

New Kids on the Block

Reduces user friction by isolating the pill identification workflow into a dedicated, lightweight application.

Capitalizes on the parent brand's extensive database to provide rapid, accurate visual identification of medications.

The outtake for UpToDate Lexidrug

Strengths to defend, gaps to attack

Core Strengths

  • Daily editorial updates establish clinical authority
  • Offline database access creates high switching costs

Critical Frictions

  • Persistent database download failures
  • UI navigation regressions hiding core tools
  • Authentication loops locking out paid subscribers

Growth Levers

  • Expand B2B institutional partnerships
  • Integrate calculators into monograph view

Market Threats

  • Drugs.com high-velocity release cadence
  • Professional migration to stable niche tools

What are the next best moves?

highInvest

Rebuild database download logic because download failures are the #1 complaint → restore core clinical utility

Database download failures are the top-cited complaint, directly preventing access to life-critical drug interaction data.

Trade-off: Pause the medical calculator UI refresh — stability is the primary churn driver.

mediumPivot

Restore drug library icon to home screen because UI navigation complaints are the #2 churn risk → improve daily workflow

User feedback explicitly requests returning the drug database icon to the main landing page to reduce menu clicks.

Trade-off: Deprioritize the new onboarding tutorial — current users are the priority for retention.

A counter-intuitive read

The app's biggest risk is not a competitor feature, but its own maintenance-mode UI, which is currently more effective at driving users to Drugs.com than any marketing campaign could.

Feature Gaps vs Competitors

  • Real-time pill identification (available in Drugs.com but missing here)
  • Social case-based learning (available in Figure 1 but missing here)

Key Takeaways

UpToDate Lexidrug maintains a strong clinical moat through editorial rigor, but technical instability in the latest release is actively driving professional churn, so the team must prioritize stability over feature expansion to protect the subscription base.

Where Is It Heading?

Declining

The professional medical reference market is consolidating around tools that provide high-speed, reliable point-of-care access. UpToDate Lexidrug's current technical instability and UI friction leave it exposed to niche competitors, so the team must shift from feature-parity to stability-first engineering to prevent further subscription loss.

Persistent database download failures prevent access to critical clinical data, which directly causes professional churn to more stable competitors.

UI navigation changes hide essential tools behind excessive menus, slowing down point-of-care workflows and reducing daily active usage.

Disclosure

Independent intel to help builders create better apps.

AI-powered analysis with editorial review, built from publicly available sources. See methodology.

Marlvel.ai is not affiliated with, endorsed by, or sponsored by UpToDate Lexidrug, its developer, the app publisher, Apple, or Google Play. All trademarks, logos, and screenshots referenced remain the property of their respective owners.

Hope this helps & keep building! · Found an error?

What's new in this report

The app's competitive position is weakening due to technical instability and UI navigation regressions that hinder professional workflows.

declined

Rating and Sentiment Score Drop

added

New Critical Complaints

shifted

Feature Competitive Positioning

added

New Competitive Threats

Cite this report

Marlvel.ai. “UpToDate Lexidrug Intelligence Report.” Updated May 20, 2026. https://marlvel.ai/intel-report/medical/com-lexi-individual

Agent Markdown (.md)·

Data licensed under CC-BY-NC 4.0